INCYTE CORP

INCY 10-Q · Q2 2025
API behind this page

INCY Q2 2025 request

Playground key active
Request URL /api/financials?ticker=INCY&year=2025&quarter=2
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric Q2 2025 Q2 2024 YoY
Revenue 1,215,529 1,043,759 +16.5%
Show Product Lines breakouts
ICLUSIG 32,729 26,862 +21.8%
JAKAFI 763,788 705,973 +8.2%
JAKAFI · US 18.7 34.6 -46.0%
JAKAVI Royalty Revenues 109,714 99,317 +10.5%
JAKAVI · Novartis 109.7 99.3 +10.5%
Milestone and contract revenues 5,000 — —
Milestone and contract revenues · Reportable Segment 5,000 — —
MINJUVI/MONJUVI 31,131 31,116 0.0%
NIKTIMVO 36,154 — —
OLUMIANT Royalty Revenues 33,482 31,702 +5.6%
OLUMIANT · Eli Lilly 33.5 31.7 +5.7%
OPZELURA 164,499 121,695 +35.2%
Other product royalty revenues 1,287 876 +46.9%
PEMAZYRE 22,192 20,269 +9.5%
Product 1,059,414 906,566 +16.9%
Product · Reportable Segment 1,059,414 906,566 +16.9%
Royalty 151,115 137,193 +10.1%
Royalty · Reportable Segment 151,115 137,193 +10.1%
TABRECTA Royalty Revenues 6,632 5,298 +25.2%
TABRECTA · Novartis 6.6 5.3 +24.5%
ZYNYZ 8,921 651 +1270.4%
Show Business Segments breakouts
Reportable Segment 1,215,529 1,043,759 +16.5%
Show Geography breakouts
Europe 78,826 53,586 +47.1%
Other countries 4,350 1,144 +280.2%
US 1,132,353 989,029 +14.5%
Cost of Revenue 78,766 76,634 +2.8%
Show Business Segments breakouts
Reportable Segment 78,766 76,634 +2.8%
Gain Loss Related To Litigation Settlement -242,251 — —
Show Product Lines breakouts
JAKAFI · Novartis -242.2 — —
Show Business Segments breakouts
Reportable Segment -242,251 — —
Research & Development 494,917 1,138,380 -56.5%
Show Asset Acquisition breakouts
Escient 679.4 — —
Show Type Of Arrangement breakouts
Syndax 5.3 4.7 +12.8%
Selling, General & Administrative 331,022 305,982 +8.2%
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 22,761 893 +2448.8%
Show Business Segments breakouts
Reportable Segment 22,761 893 +2448.8%
Total Costs & Expenses 685,215 1,521,889 -55.0%
Operating Income 530,314 -478,130 +210.9%
Interest Income 25,136 41,476 -39.4%
Interest Expense -594 -657 +9.6%
Equity Securities Fv Ni Gain Loss -4,151 39,241 -110.6%
Other Non-Operating Income (Expense) 7,307 8,293 -11.9%
Income Before Taxes 558,012 -389,777 +243.2%
Income Tax Expense (Benefit) 153,013 54,824 +179.1%
Net Income 404,999 -444,601 +191.1%
Show Business Segments breakouts
Reportable Segment 404,999 -444,601 +191.1%
Show Equity Components breakouts
Retained Earnings 404,999 -444,601 +191.1%
EPS (Basic) 2.09 -2.04 +202.5%
EPS (Diluted) 2.04 -2.04 +200.0%
Wtd Avg Shares (Basic) 193,995 218,175 -11.1%
Wtd Avg Shares (Diluted) 198,744 218,175 -8.9%
Sales & Marketing (Q) — — —
Show Business Segments breakouts
Reportable Segment 256,311 229,202 +11.8%
General & Administrative (Q) — — —
Show Business Segments breakouts
Reportable Segment 74,711 76,780 -2.7%
Comprehensive Income 424,676 -443,849 +195.7%
Other Comprehensive Income 19,677 752 +2516.6%
Show Equity Components breakouts
Accumulated Other Comprehensive Income 19,677 752 +2516.6%
Net Income Loss Available To Common Stockholders Basic 404,999 -444,601 +191.1%

Balance Sheet

Balance Sheet
Metric Q2 2025 Q2 2024 YoY
Current Assets
Cash & Cash Equivalents 1,954,969 987,293 +98.0%
Debt Securities Available For Sale Excluding Accrued Interest Current 466,769 — —
Accounts Receivable Net 842,892 739,050 +14.1%
Inventory 83,423 100,704 -17.2%
Prepaid Expenses & Other Current Assets 295,648 207,956 +42.2%
Total Current Assets 3,643,701 2,567,085 +41.9%
Non-Current Assets
Restricted Cash Noncurrent 1,844 1,631 +13.1%
Equity Securities F V N I Noncurrent 13,313 — —
Show Fair Value Hierarchy breakouts
Fair Value Inputs Level1 · Fair Value Measurements Recurring 13,313 — —
Show Schedule Of Equity Method Investment Equity Method Investee Name breakouts
Investment in Syndax 13.3 — —
Show Fair Value By Measurement Basis breakouts
Estimate Of Fair Value Fair Value Disclosure · Fair Value Measurements Recurring 13,313 — —
Inventory Noncurrent 368,108 255,268 +44.2%
Property, Plant & Equipment 798,543 — —
Show Geography breakouts
CH 310,206 — —
Other countries 13,953 — —
US 474,384 — —
Goodwill 155,593 155,593 0.0%
Deferred Tax Assets 652,280 729,561 -10.6%
Other Non-Current Assets 32,552 21,917 +48.5%
Total Assets 5,821,354 4,661,803 +24.9%
Other Assets
Finance Lease Right Of Use Asset 29,001 25,535 +13.6%
Other Intangible Assets Net 126,419 113,536 +11.3%
Current Liabilities
Accounts Payable 241,094 148,174 +62.7%
Employee Related Liabilities Current 129,114 113,536 +13.7%
Accrued Liabilities 857,094 1,034,316 -17.1%
Finance Lease Liability Current 4,475 3,874 +15.5%
Business Combination Contingent Consideration Liability Current 46,842 37,155 +26.1%
Total Current Liabilities 1,278,619 1,337,055 -4.4%
Non-Current Liabilities
Business Combination Contingent Consideration Liability Noncurrent 160,158 156,845 +2.1%
Finance Lease Liability Noncurrent 31,760 28,745 +10.5%
Other Non-Current Liabilities 179,914 142,099 +26.6%
Total Liabilities 1,650,451 1,664,744 -0.9%
Stockholders' Equity
Common Stock 194 191 +1.6%
Additional Paid In Capital Common Stock 4,666,949 4,382,734 +6.5%
Accumulated Other Comprehensive Income 13,439 -5,420 +348.0%
Retained Earnings -509,679 -1,380,446 +63.1%
Total Stockholders' Equity 4,170,903 2,997,059 +39.2%
Show Equity Components breakouts
Accumulated Other Comprehensive Income 13,439 -5,420 +348.0%
Additional Paid In Capital 4,666,949 4,382,734 +6.5%
Common Stock 194 191 +1.6%
Retained Earnings -509,679 -1,380,446 +63.1%
Total Liabilities & Equity 5,821,354 4,661,803 +24.9%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q2 2025 YTD Q2 2024 YoY
Operating Activities
Net Income 563,202 -275,053 +304.8%
Depreciation & Amortization 45,281 43,995 +2.9%
Stock-Based Compensation 125,591 116,418 +7.9%
Increase Decrease In Deferred Income Taxes 110,071 -51,733 +312.8%
Other Non-Cash Items -3,220 2,588 -224.4%
Change in Accounts Receivable 10,726 4,507 +138.0%
Change in Prepaid & Other Assets -148,440 -39,748 -273.5%
Change in Inventory -48,099 -84,976 +43.4%
Change in Accounts Payable 17,752 38,573 -54.0%
Increase Decrease In Accrued Liabilities -401,883 27,428 -1565.2%
Net Cash from Operations 310,808 -356,752 +187.1%
Investing Activities
Proceeds From Sale Of Longterm Investments 7 227,257 -100.0%
Payments To Acquire Other Productive Assets -22,243 -63,692 +65.1%
Payments To Acquire Marketable Securities -97,346 -204,091 +52.3%
Proceeds From Sale And Maturity Of Marketable Securities 101,807 182,634 -44.3%
Net Cash from Investing -17,775 140,708 -112.6%
Financing Activities
Payments For Repurchase Of Common Stock Excise Tax -19,100 — —
Proceeds From Stock Plans 18,123 14,960 +21.1%
Tax Withholding for Share Compensation -10,366 -6,865 -51.0%
Finance Lease Principal Payments -2,245 -1,782 -26.0%
Payment Of Contingent Consideration -10,334 -11,216 +7.9%
Net Cash from Financing -23,922 -2,009,590 +98.8%
Supplemental
Income Taxes Paid 177,919 229,674 -22.5%
Loss Contingency Accrual Payments 294,881 — —
Intangible Assets Purchased But Not Yet Paid 25,000 — —
Unpaid Capital Expenditures 4,046 800 +405.8%
Right Of Use Asset Obtained In Exchange For Operating Lease Liability 1,768 2,188 -19.2%
Right Of Use Asset Obtained In Exchange For Finance Lease Liability 304 1,468 -79.3%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents -1,749 -663 -163.8%
Net Change in Cash 267,362 -2,226,297 +112.0%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1,956,813 988,924 +97.9%

Values in thousands USD. Source: SEC EDGAR 10-Q filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key